Dr Rasha Al-Lamee
Consultant Interventional Cardiologist, Imperial College Healthcare Trust, London
Dr Rasha Al-Lamee is an Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust and a Clinical Senior Lecturer at the National Heart and Lung Institute within Imperial College London. She is a clinical trialist with expertise in stable coronary artery disease, coronary intervention, invasive physiology and invasive intravascular imaging.
She leads a research group with a focus on clinical trials that impact the care of patients with cardiovascular disease. She believes in rigorous testing of clinical practice and the use of evidence-based medicine in all aspects of medical care.
She designed, conducted and led ORBITA, the first randomised placebo-controlled trial of coronary angioplasty. ORBITA is one of the most widely cited clinical trials in cardiology of the decade. She is lead author of the primary publication in The Lancet and the two secondary analyses both published in Circulation.
She is the NIHR CRN North West London Cardiovascular specialty lead and is actively involved in the development and recruitment for a number of multi-centre international clinical trials.